-
Oct 28, 2022
news release
AI drug discovery company Elix commences joint research with proprietary screening technology holder SEEDSUPPLY
-
Aug 31, 2022
news release
Elix and DeNA Life Science Reach Basic Agreement for Collaboration
-
Jul 15, 2022
news release
Elix launches “Elix Discovery™,” the only all-in-one platform that provides everything needed for AI drug discovery, from models for property prediction and molecular design to AI consulting and implementation support
-
Mar 25, 2022
news release
Elix, Inc. begins collaboration with Shionogi & Co., Ltd. on Elix Synthesize (AI Drug Discovery Module) for verification of practical retrosynthetic analysis
-
Feb 9, 2022
news release
kMoL, a Machine Learning Library for AI Drug Discovery With Federated Learning Capabilities
-
Sep 1, 2020
news release
Elix launches joint research on AI drug discovery with Astellas Pharma
-
Jul 13, 2020
news release
Elix applied machine learning to predict potential drug candidates against COVID-19
-
Jun 23, 2020
news release
Elix Developed an AI Solution for Monitoring Crowd Density and Crowd Counting to Prevent the Spread of COVID-19
-
Oct 8, 2019
news release
Elix is chosen for pharmaceutical & medical startup acceleration program, ”Blockbuster TOKYO”
-
Aug 7, 2017
news release
Have been selected for the NVIDIA Inception Program
